Rituximab-associated Vasculitis Flare: Incidence, Predictors, and Outcome

REFERENCES

1. 1.↵
   1. Kumar A,
   2. Khamkar K,
   3. Gopal H

   . Serum sickness and severe angioedema following rituximab therapy in RA. Int J Rheum Dis 2012;15:e6–7.

   OpenUrlPubMed
2. 2.↵
   1. Hellerstedt B,
   2. Ahmed A

   . Delayed-type hypersensitivity reaction or serum sickness after rituximab treatment. Ann Oncol 2003;14:1792.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Seror R,
   2. Sordet C,
   3. Guillevin L,
   4. Hachulla E,
   5. Masson C,
   6. Ittah M,
   7. et al.

   Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome. Ann Rheum Dis 2007;66:351–7.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Sène D,
   2. Ghillani-Dalbin P,
   3. Amoura Z,
   4. Musset L,
   5. Cacoub P

   . Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum 2009;60:3848–55.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Zenone T

   . Flare of essential mixed cryoglobulinemic vasculitis with hemorrhagic bullous purpura after rituximab infusion. Int J Rheum Dis 2013;16:237–9.

   OpenUrl
6. 6.↵
   1. Karmacharya P,
   2. Poudel DR,
   3. Pathak R,
   4. Donato AA,
   5. Ghimire S,
   6. Giri S,
   7. et al.

   Rituximab-induced serum sickness: a systematic review. Semin Arthritis Rheum 2015;45:334–40.

   OpenUrl
7. 7.↵
   1. Gérard L,
   2. Michot JM,
   3. Burcheri S,
   4. Fieschi C,
   5. Longuet P,
   6. Delcey V,
   7. et al.

   Rituximab decreases the risk of lymphoma in patients with HIV-associated multicentric Castleman disease. Blood 2012;119:2228–33.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Strait RT,
   2. Posgai MT,
   3. Mahler A,
   4. Barasa N,
   5. Jacob CO,
   6. Köhl J,
   7. et al.

   IgG1 protects against renal disease in a mouse model of cryoglobulinaemia. Nature 2015;517:501–4.

   OpenUrlPubMed
9. 9.↵
   1. Karsten CM,
   2. Pandey MK,
   3. Figge J,
   4. Kilchenstein R,
   5. Taylor PR,
   6. Rosas M,
   7. et al.

   Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat Med 2012;18:1401–6.

   OpenUrlCrossRefPubMed